methylnitrosourea has been researched along with ro 24-5531 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anver, MR; Anzano, MA; Brown, CC; Driver, CL; Green, DM; Logsdon, DL; Lucia, MS; Peer, CW; Shrader, MW; Slayter, MV | 1 |
| Anzano, MA; Driver, CL; Letterio, JJ; Logsdon, DL; Mullen, LT; Peer, CW; Shrader, MW; Smith, JM; Uskoković, MR; Welsh, MC | 1 |
2 other study(ies) available for methylnitrosourea and ro 24-5531
| Article | Year |
|---|---|
Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.
Topics: Androgens; Animals; Anticarcinogenic Agents; Calcitriol; Carcinogens; Drug Screening Assays, Antitumor; Male; Methylnitrosourea; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Seminal Vesicles; Tamoxifen; Testosterone | 1995 |
1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Breast Neoplasms; Calcitriol; Calcium; Cell Division; Cell Line; Diet; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasm Invasiveness; Rats; Rats, Sprague-Dawley; Tamoxifen; Tumor Cells, Cultured | 1994 |